finlay minerals ltd. (TSXV: FYL,OTC:FYMNF) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’) is pleased to announce…
Author
admin
-
-
-
-
-
-
-
Investing
Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
by adminThe ESC M&PD meeting brings together the world’s experts working to improve the treatment of…
-
-
-